Genezen Laboratories Inc. a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has further strengthened its senior leadership team with the appointment of Brok Weichbrodt as Vice President of Operations. Previously the Director of...

Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production and analytical testing services, has broken ground on a new multiphase master plan for a...

  Following major growth, Genezen Laboratories Inc, a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has announced the appointment of three board members: Iain Baird, Diana Caldwell and Tedd Green. The expansion of the team...

Genezen Laboratories, Inc., a cell and gene therapy Contract Development and Manufacturing Organization (CDMO) focused on early-phase process development, vector production, and analytical testing services, today announced a majority investment from Ampersand Capital...

Indiana Business Journal has named Genezen Laboratories the fastest growing company in central Indiana! Revenue growth FY 2017 to 2019: 424% 2019 revenue: $15.1 million Light bulb moment: Bill Vincent had been working for the Indianapolis company Rimedion, which was...

We are extremely grateful to the City of Fishers and to the IEDC for making Fishers a supportive place to grow our business,” said Bill Vincent, CEO of Genezen Labs. “Gene and cell therapies have shown amazing potential in treating cancer and rare genetic disorders,...

Genezen Laboratories has initiated its research and development efforts with a new lab opening at the Indiana Center for Biomedical Innovation (ICBI). The R&D program at Genezen Labs focuses on the development of new tools for gene therapy. These tools will...